Concepedia
2
Publications
31
Citations
H-Index
2022
Active since
Affiliations
Lushang (China)(Current)
Zhaohui Leng is an author at Lushang (China).
Publications per year
2022–2023
LPCAT1 promotes gefitinib resistance via upregulation of the EGFR/PI3K/AKT signaling pathway in lung adenocarcinoma
Jianghua Ding, Xinjing Ding, Zhaohui Leng · Journal of Cancer · 2022 · 19 citations · Full text
Etoposide/platinum plus anlotinib for patients with transformed small-cell lung cancer from EGFR-mutant lung adenocarcinoma after EGFR-TKI resistance: a retrospective and observational study
Jianghua Ding, Zhaohui Leng, Hong Gu et al. · Frontiers in Oncology · 2023 · 12 citations · Full text
Rows per page
1–2 of 2